Astley et al., 2009 - Google Patents
Magnetic resonance spectroscopy outcomes from a comprehensive magnetic resonance study of children with fetal alcohol spectrum disordersAstley et al., 2009
View PDF- Document ID
- 12406665867084571696
- Author
- Astley S
- Richards T
- Aylward E
- Olson H
- Kerns K
- Brooks A
- Coggins T
- Davies J
- Dorn S
- Gendler B
- Jirikowic T
- Kraegel P
- Maravilla K
- Publication year
- Publication venue
- Magnetic resonance imaging
External Links
Snippet
Magnetic resonance (MR) technology offers noninvasive methods for in vivo assessment of neuroabnormalities. A comprehensive neuropsychological/behavioral, MR imaging (MRI), MR spectroscopy (MRS) and functional MRI (fMRI) assessment was administered to children …
- 201000007658 fetal alcohol spectrum disease 0 title abstract description 80
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/54—Signal processing systems, e.g. using pulse sequences, Generation or control of pulse sequences ; Operator Console
- G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
- G01R33/563—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution of moving material, e.g. flow contrast angiography
- G01R33/56341—Diffusion imaging
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/4806—Functional imaging of brain activation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/483—NMR imaging systems with selection of signals or spectra from particular regions of the volume, e.g. in vivo spectroscopy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/46—NMR spectroscopy
- G01R33/465—NMR spectroscopy applied to biological material, e.g. in vitro testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radiowaves
- A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radiowaves involving electronic or nuclear magnetic resonance, e.g. magnetic resonance imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Astley et al. | Magnetic resonance spectroscopy outcomes from a comprehensive magnetic resonance study of children with fetal alcohol spectrum disorders | |
| Soares et al. | Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications | |
| Saunders et al. | Aging of the adult human brain: in vivo quantitation of metabolite content with proton magnetic resonance spectroscopy | |
| Bertolino et al. | Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging | |
| Davanzo et al. | Decreased anterior cingulate myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder | |
| Bernasconi et al. | Magnetic resonance spectroscopy and imaging of the thalamus in idiopathic generalized epilepsy | |
| Friedman et al. | Regional brain chemical alterations in young children with autism spectrum disorder | |
| Suhy et al. | Early detection and longitudinal changes in amyotrophic lateral sclerosis by 1H MRSI | |
| Weiduschat et al. | Usefulness of proton and phosphorus MR spectroscopic imaging for early diagnosis of Parkinson's disease | |
| Chaumeil et al. | pH as a biomarker of neurodegeneration in Huntington's disease: a translational rodent-human MRS study | |
| Tedeschi et al. | Proton magnetic resonance spectroscopic imaging in childhood ataxia with diffuse central nervous system hypomyelination | |
| Li et al. | Evaluating metabolites in patients with major depressive disorder who received mindfulness-based cognitive therapy and healthy controls using short echo MRSI at 7 Tesla | |
| Grachev et al. | Aging alters the multichemical networking profile of the human brain: an in vivo1H‐MRS study of young versus middle‐aged subjects | |
| Coplan et al. | Reduced hippocampal N-acetyl-aspartate (NAA) as a biomarker for overweight | |
| Weber et al. | Proton magnetic resonance spectroscopy of prefrontal white matter in psychotropic naïve children and adolescents with obsessive–compulsive disorder | |
| Hammen et al. | Clinical applications of 1H‐MR spectroscopy in the evaluation of epilepsies–What do pathological spectra stand for with regard to current results and what answers do they give to common clinical questions concerning the treatment of epilepsies? | |
| Schuff et al. | Reanalysis of multislice 1H MRSI in amyotrophic lateral sclerosis | |
| Wang et al. | Metabolic alterations of the dorsolateral prefrontal cortex in sleep‐related hypermotor epilepsy: A proton magnetic resonance spectroscopy study | |
| Hammen et al. | Magnetic resonance spectroscopy in epilepsy | |
| Azilinon et al. | Combining sodium MRI, proton MR spectroscopic imaging, and intracerebral EEG in epilepsy | |
| Hammen et al. | Identifying the affected hemisphere by 1H‐MR spectroscopy in patients with temporal lobe epilepsy and no pathological findings in high resolution MRI | |
| Hatchondo et al. | 1H magnetic resonance spectroscopy suggests neural membrane alteration in specific regions involved in obsessive-compulsive disorder | |
| Colla et al. | MR spectroscopy in Alzheimer’s disease: gender differences in probabilistic learning capacity | |
| Glodzik et al. | Memantine decreases hippocampal glutamate levels: a magnetic resonance spectroscopy study | |
| Kumar et al. | Neurometabolite changes in hyperthyroid patients before and after antithyroid treatment: an in vivo 1H MRS study |